Services

Protocol Design:

Assist internal and external stakeholders on projects of major concern, and make needs assessment.
Protocol design, subject recruitment and care, IRB write–up, sample procurement, MTA agreements.
Basic and clinical studies on CD and NCD that are associated with oncogenic viruses.
Assist pharmaceutical industries to design and implement studies in African countries testing cutting edge drugs, vaccines, biomarkers, determine pathways associated with the diseases, and initiating clinical trials/studies.

Knowledge Transfer:

Advice short-term oncologists to African hospitals and universities on knowledge exchange on the types of cancer they are seeing and developments in the field.
Motivate African oncologists and researchers to learn new techniques on cancer research and treatment.Consult with pharmaceutical industries and universities on design of viral oncology studies applicable to the African situation.
Advice the health sector and NGOs in African countries on knowledge dissemination about viral-associated cancers.

New Studies:

Genome studies: Study diseases influenced by ethnicity, nature-nurture and epigenetics.
Rekindle studies of emerging and re-emerging diseases.
New techniques in identifying cancer biomarkers and prognosis of disease

Meetings:

Set up conferences, symposiums, and forums on the continent addressing CD and NCD for the African countries, governments, Foundations, NGOs, and Pharmaceutical companies with interest in these diseases in Africa.

Policy:

Advice African leaders, health care workers, and researchers on dealing with current health issues, in the phase of very difficult economic times, and in a period when infectious diseases have not been eradicated and new emerging diseases and “Western chronic diseases” are increasing exponentially, but especially in urban areas; a consequence of rapid development and technological changes among the educated and the uneducated, rural vs. urban that unless addressed now will have a negative impact on the economy in the near future.
Work with governments, regulatory agencies, medical institutions and pharmaceutical companies on strategic health plans, implementations and testing of new technologies and paradigms for treatment that are sustainable especially for CD and NCD.

Procurement:

Africa: